HomeEYPT • NASDAQ
add
Eyepoint Pharmaceuticals Inc
Nakaraang pagsara
$8.93
Sakop ng araw
$8.91 - $9.29
Sakop ng taon
$3.91 - $13.99
Market cap
625.50M USD
Average na Volume
820.74K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 24.45M | 109.29% |
Gastos sa pagpapatakbo | 14.88M | 3.32% |
Net na kita | -45.20M | -54.33% |
Net profit margin | -184.82 | 26.26% |
Kita sa bawat share | -0.65 | -18.18% |
EBITDA | -48.34M | -46.40% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 318.19M | 6.30% |
Kabuuang asset | 362.56M | 10.12% |
Kabuuang sagutin | 64.17M | -19.10% |
Kabuuang equity | 298.40M | — |
Natitirang share | 68.81M | — |
Presyo para makapag-book | 2.06 | — |
Return on assets | -31.26% | — |
Return on capital | -35.80% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -45.20M | -54.33% |
Cash mula sa mga operasyon | -53.12M | -70.41% |
Cash mula sa pag-invest | 39.52M | 89.97% |
Cash mula sa financing | -951.00K | -926.96% |
Net change in cash | -14.55M | -41.91% |
Malayang cash flow | -26.77M | -80.31% |
Tungkol
EyePoint Pharmaceuticals Inc. is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems and nanotechnology to drug delivery.
pSivida obtained porous silicon technology from the British government Defence Evaluation and Research Agency. QinetiQ continues to be a strategic partner.
In June 2004, pSivida acquired full ownership of pSiMedica. In April 2018, pSivida purchased eye products firm Icon Bioscience. Afterwards, it rebranded to its current name of EyepOint Pharmaceuticals, Inc. Wikipedia
Itinatag
1987
Headquarters
Website
Mga Empleyado
165
